Alcohol Withdrawal Syndrome
📧 Sign up to get email alerts when something new happens for Alcohol Withdrawal Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA) [Phase 3]
Phase 3 clinical trial completed evaluating magnesium adjunct in alcohol withdrawal syndrome (MAGMA).
-
FDA approval · 2021-11-12FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Diazepam from Hikma Pharmaceuticals USA Inc. under an ANDA, reflecting a regulatory action on th…
-
FDA approval · 2021-06-23FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approved Natco Pharma USA LLC's supplemental application for Diazepam (generic).
-
FDA approval · 2021-05-17FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for diazepam filed by Hikma Pharmaceuticals USA Inc., marking regulatory clearance for an additi…
-
FDA approval · 2021-03-25FDA Approved: DIAZEPAM — Supplemental Application (Oceanside Pharmaceuticals)
FDA supplemental approval for Diazepam under Oceanside Pharmaceuticals is recorded, confirming the approval of a supplemental application fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-02-08FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approved a supplemental application for Diazepam (generic) from Natco Pharma USA LLC under an ANDA. The action confirms approval of the …
-
FDA approval · 2021-02-08FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approved a supplemental application for Diazepam from Natco Pharma USA LLC (ANDA 211998). This action confirms the continued approval/av…
-
FDA approval · 2021-02-05FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a supplemental application for chlordiazepoxide hydrochloride from Epic Pharma LLC. The approval pertains to the generic produc…
-
FDA approval · 2021-02-05FDA Approved: DIAZEPAM INTENSOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Diazepam Intensol from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2021-02-05FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for diazepam from Hospira, Inc., under an ANDA, indicating regulatory approval of the requested chan…
-
FDA approval · 2021-02-05FDA Approved: DIAZEPAM — Supplemental Application (Meridian Medical Technologies LLC)
The FDA approved a supplemental application for Diazepam submitted by Meridian Medical Technologies LLC.
-
FDA approval · 2021-02-05FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for chlordiazep oxide hydrochloride from Epic Pharma, LLC.
-
FDA approval · 2021-02-05FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for diazepam from Hikma Pharmaceuticals USA Inc. to market a generic diazepam product.
-
FDA approval · 2021-02-05FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a supplemental application for chlordiazepoxide hydrochloride by Epic Pharma LLC, indicating a regulatory modification to an ap…
-
FDA approval · 2021-02-05FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Diazepam, approving a generic version of the drug.
-
FDA approval · 2020-08-17FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for diazepam from Hikma Pharmaceuticals USA Inc., updating the approved product under the existi…
-
FDA approval · 2019-12-26FDA Approved: DIAZEPAM — Original Application (Natco Pharma USA LLC)
FDA approved Natco Pharma USA LLC's original application for a generic diazepam product, enabling its marketing in the United States.
-
FDA approval · 2019-11-06FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
The FDA approved a supplemental application for Diazepam from Natco Pharma USA LLC, granting approval of generic diazepam under ANDA210363.
-
CLINICAL_TRIALS withdrawal · 2019-09-19Clinical Trial Update: Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine [Phase 4]
Phase 4 clinical trial update for alcohol withdrawal syndrome using adjunctive phenobarbital or ketamine; study withdrawn.
-
FDA approval · 2019-02-21FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Diazepam filed by Hospira, Inc. (ANDA 072079).
-
FDA approval · 2019-02-21FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application for diazepam from Hospira, Inc., indicating updated labeling and continued availability under th…
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: Preventing Alcohol Withdrawal Syndrome With Oral Baclofen [Phase 3]
Phase 3 clinical trial evaluating oral baclofen to prevent alcohol withdrawal syndrome was terminated; results were posted.
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Hyperbaric Oxygenation in Treatment of Alcohol Dependence Syndrome [NA]
A completed clinical trial evaluating hyperbaric oxygen therapy for alcohol withdrawal symptoms and delirium tremens.
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms. [NA]
This clinical trial update notes the completion of a study assessing energetic resonance via cutaneous stimulation for managing withdrawal s…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Assessment of Valproate on Ethanol Withdrawal [Phase 4]
Phase 4 clinical trial evaluating valproate for ethanol withdrawal in individuals with alcohol-related disorders; current status is not disc…